RU2018145945A3 - - Google Patents

Download PDF

Info

Publication number
RU2018145945A3
RU2018145945A3 RU2018145945A RU2018145945A RU2018145945A3 RU 2018145945 A3 RU2018145945 A3 RU 2018145945A3 RU 2018145945 A RU2018145945 A RU 2018145945A RU 2018145945 A RU2018145945 A RU 2018145945A RU 2018145945 A3 RU2018145945 A3 RU 2018145945A3
Authority
RU
Russia
Application number
RU2018145945A
Other languages
Russian (ru)
Other versions
RU2018145945A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018145945A publication Critical patent/RU2018145945A/ru
Publication of RU2018145945A3 publication Critical patent/RU2018145945A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2018145945A 2016-06-10 2017-06-09 Пептид для лечения остеоартрита, фармацевтическая композиция, лекарственное средство, единичная дозированная форма RU2018145945A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16174056.8 2016-06-10
EP16174056 2016-06-10
PCT/EP2017/064196 WO2017212057A1 (en) 2016-06-10 2017-06-09 Peptides for the treatment of osteoarthritis

Publications (2)

Publication Number Publication Date
RU2018145945A RU2018145945A (ru) 2020-07-10
RU2018145945A3 true RU2018145945A3 (cg-RX-API-DMAC7.html) 2020-07-10

Family

ID=56132793

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018145945A RU2018145945A (ru) 2016-06-10 2017-06-09 Пептид для лечения остеоартрита, фармацевтическая композиция, лекарственное средство, единичная дозированная форма

Country Status (12)

Country Link
US (1) US10813980B2 (cg-RX-API-DMAC7.html)
EP (1) EP3468582A1 (cg-RX-API-DMAC7.html)
JP (1) JP7010934B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190018466A (cg-RX-API-DMAC7.html)
CN (1) CN109862905A (cg-RX-API-DMAC7.html)
AU (1) AU2017277747A1 (cg-RX-API-DMAC7.html)
BR (1) BR112018075613A2 (cg-RX-API-DMAC7.html)
CA (1) CA3026984A1 (cg-RX-API-DMAC7.html)
IL (1) IL263564B (cg-RX-API-DMAC7.html)
MA (1) MA45227A (cg-RX-API-DMAC7.html)
RU (1) RU2018145945A (cg-RX-API-DMAC7.html)
WO (1) WO2017212057A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108785661A (zh) * 2018-07-20 2018-11-13 深圳市第二人民医院 一种无副作用治疗退行性骨关节病的注射剂及其制备方法
MY204234A (en) 2018-08-27 2024-08-16 Regeneron Pharma Use of raman spectroscopy in downstream purification
KR102856432B1 (ko) 2022-02-23 2025-09-08 중앙대학교 산학협력단 졸참나무 잎 추출물을 유효성분으로 포함하는 골관절염 예방 또는 치료용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1208760B (it) * 1986-11-04 1989-07-10 Ind Farmaceutica Serono S P A Trattamento delle malattie infiammatorie articolari
FR2833012B1 (fr) 2001-12-04 2004-01-30 Centre Nat Rech Scient Peptides agonistes de l'hormone de croissance et leurs applications
US20040127402A1 (en) * 2002-12-27 2004-07-01 Vad Vijay B. Injectible composition and method for treating degenerative animal joints
US7803781B2 (en) 2003-02-28 2010-09-28 Isis Pharmaceuticals, Inc. Modulation of growth hormone receptor expression and insulin-like growth factor expression
US20070184015A1 (en) 2006-02-03 2007-08-09 Soonkap Hahn Novel PEGylation agent
WO2010105685A1 (en) 2009-03-19 2010-09-23 Universite Pierre Et Marie Curie Peptides for inhibiting igf-1
EP2502632B1 (en) 2009-11-18 2016-12-28 Asahi Kasei Pharma Corporation Preventative agent and/or therapeutic agent and/or exacerbation-suppressing agent for human knee osteoarthritis

Also Published As

Publication number Publication date
RU2018145945A (ru) 2020-07-10
EP3468582A1 (en) 2019-04-17
WO2017212057A1 (en) 2017-12-14
IL263564B (en) 2021-07-29
BR112018075613A2 (pt) 2019-04-09
US10813980B2 (en) 2020-10-27
JP7010934B2 (ja) 2022-02-10
JP2019522046A (ja) 2019-08-08
US20190298808A1 (en) 2019-10-03
MA45227A (fr) 2019-04-17
IL263564A (en) 2019-02-03
CN109862905A (zh) 2019-06-07
KR20190018466A (ko) 2019-02-22
CA3026984A1 (en) 2017-12-14
AU2017277747A1 (en) 2019-01-17

Similar Documents

Publication Publication Date Title
BR112018068177A2 (cg-RX-API-DMAC7.html)
BR112019002665A2 (cg-RX-API-DMAC7.html)
BR112018004986A2 (cg-RX-API-DMAC7.html)
BR112019001429A2 (cg-RX-API-DMAC7.html)
BR212018070320U2 (cg-RX-API-DMAC7.html)
BR112019011044B1 (pt) Compostos de pirazol substituído, seu uso, e composição farmacêutica
BR112019008501B1 (pt) Método realizado por um equipamento de usuário, método realizado por um nó de rede, equipamento de usuário, nó de rede, e, meios de armazenamento legíveis por computador
BR112019003116B1 (pt) Configuração de símbolo de rajada comum de uplink
BR112018076493B1 (pt) Sistemas e métodos para detecção de posição de feixe de luz
BR112018073794B1 (pt) Partícula, método de geração da partícula, vacina ou composição farmacêutica
BR122026002520A2 (pt) Célula, conjunto de vetores para expressar uma proteína de ligação a antígeno biespecífica em uma célula, conjunto de vetores, sistema, método, e, método para produção de uma proteína de ligação a antígeno
BR112019009373A2 (cg-RX-API-DMAC7.html)
BR112019006736A2 (cg-RX-API-DMAC7.html)
BR112019003108A2 (cg-RX-API-DMAC7.html)
CN303647635S (zh) 庭审直播主机(高清环通)
CN303555763S (zh) 女士手提包(沉鱼)
CN303537476S (zh) 飞碟吊椅
CN303561652S (zh) 机械人体秤(dt02-b)
CN303536045S (zh) 嫁衣(15)
CN303633654S (zh) 手表(十二星座系列b)
CN303536877S (zh) 涤纶长丝无纺布
CN303596988S (zh) 卧式加工中心(mdh系列)
CN303536111S (zh) 眼罩(条纹)
CN303536110S (zh) 眼罩(花纹)
CN303537445S (zh) 凳子(2075)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20201019

FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20210803

FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20220117